Добірка наукової літератури з теми "Tyrosine Kinase Inhibitors Targeting"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Tyrosine Kinase Inhibitors Targeting".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Tyrosine Kinase Inhibitors Targeting"
Deininger, Michael. "Targeting Tyrosine Kinase Receptors." Blood 122, no. 21 (November 15, 2013): SCI—25—SCI—25. http://dx.doi.org/10.1182/blood.v122.21.sci-25.sci-25.
Повний текст джерелаChen, Jin-Shuen, Li-Chien Chang, Shyh-Jer Huang, and Chao-Wen Cheng. "Targeting Spleen Tyrosine Kinase-Bruton’s Tyrosine Kinase Axis for Immunologically Mediated Glomerulonephritis." BioMed Research International 2014 (2014): 1–6. http://dx.doi.org/10.1155/2014/814869.
Повний текст джерелаForster, Michael, Xiaojun Julia Liang, Martin Schröder, Stefan Gerstenecker, Apirat Chaikuad, Stefan Knapp, Stefan Laufer, and Matthias Gehringer. "Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK." International Journal of Molecular Sciences 21, no. 23 (December 4, 2020): 9269. http://dx.doi.org/10.3390/ijms21239269.
Повний текст джерелаManzo, Lawaly Maman, Moudirat Lawaly, and Lui YU. "Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small cell lung cancer." Indian Journal of Pharmaceutical and Biological Research 3, no. 02 (June 30, 2015): 81–87. http://dx.doi.org/10.30750/ijpbr.3.2.10.
Повний текст джерелаCher, Chae Yin, Cheuk Him Man, Stephen S. Y. Lam, Eric S. K. Ho, Nelson K. L. Ng, Marie-Anne Hospital, Jerome Tamburini, and Anskar Y. H. Leung. "Targeting Polo-like Kinase in Acute Myeloid Leukemia." Blood 124, no. 21 (December 6, 2014): 2234. http://dx.doi.org/10.1182/blood.v124.21.2234.2234.
Повний текст джерелаGrimminger, Friedrich, Ralph T. Schermuly, and Hossein A. Ghofrani. "Targeting non-malignant disorders with tyrosine kinase inhibitors." Nature Reviews Drug Discovery 9, no. 12 (December 2010): 956–70. http://dx.doi.org/10.1038/nrd3297.
Повний текст джерелаPasquet, Jean-Max, Romain Gioia, Claire Drullion, Valerie Lagarde, Cedric Leroy, Serge Roche, Bruno Cardinaud, and Francois-Xavier Mahon. "Tyrosine Kinase Proteins profiling of Nilotinib Resistant Chronic Myelogenous Leukemia Cells Unravels a Tyrosine Kinase-Mediated Bypass." Blood 114, no. 22 (November 20, 2009): 2175. http://dx.doi.org/10.1182/blood.v114.22.2175.2175.
Повний текст джерелаSakle, Nikhil S., Shweta A. More, Sachin A. Dhawale, and Santosh N. Mokale. "Targeting Small Molecule Tyrosine Kinases by Polyphenols: New Move Towards Anti-tumor Drug Discovery." Current Drug Discovery Technologies 17, no. 5 (December 23, 2020): 585–615. http://dx.doi.org/10.2174/1570163816666190808120843.
Повний текст джерелаvan der Kuip, Heiko, Lara Wohlbold, Carsten Oetzel, Matthias Schwab, and Walter E. Aulitzky. "Mechanisms of Clinical Resistance to Small Molecule Tyrosine Kinase Inhibitors Targeting Oncogenic Tyrosine Kinases." American Journal of PharmacoGenomics 5, no. 2 (2005): 101–12. http://dx.doi.org/10.2165/00129785-200505020-00003.
Повний текст джерелаShojaee, Seyedmehdi, Maike Buchner, Huimin Geng, Bolland Silvia, Phillip Koeffler, and Markus Muschen. "Targeting Inhibitory Phosphatases in Tyrosine Kinase-Driven Leukemias." Blood 118, no. 21 (November 18, 2011): 1382. http://dx.doi.org/10.1182/blood.v118.21.1382.1382.
Повний текст джерелаДисертації з теми "Tyrosine Kinase Inhibitors Targeting"
Aljohani, Hashim M. "Targeting Tyrosine Kinase Drug Resistance Mechanisms and Metastatic Pathways in Brain Tumors." University of Cincinnati / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1595846160285645.
Повний текст джерелаPadi, Sathish K. R., Libia A. Luevano, Ningfei An, Ritu Pandey, Neha Singh, Jin H. Song, Jon C. Aster, Xue-Zhong Yu, Shikhar Mehrotra, and Andrew S. Kraft. "Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset." IMPACT JOURNALS LLC, 2017. http://hdl.handle.net/10150/624055.
Повний текст джерелаZielger, David Women's & Children's Health Faculty of Medicine UNSW. "Targeting anti-apoptotic mechanisms in malignant gliomas." Awarded by:University of New South Wales. Women's & Children's Health, 2009. http://handle.unsw.edu.au/1959.4/43713.
Повний текст джерелаMukhtar, Lenah. "Targeting the Mevalonate Pathway Enhances the Efficacy of Epidermal Growth Factor Receptor – Tyrosine Kinase Inhibitors in Head and Neck Squamous Cell Carcinoma." Thesis, Université d'Ottawa / University of Ottawa, 2020. http://hdl.handle.net/10393/40391.
Повний текст джерелаHamilton, Julie Anne. "Targeting epithelial-to-mesenchymal transition (EMT) in feline oral squamous cell carcinoma (FOSCC)." Thesis, University of Edinburgh, 2018. http://hdl.handle.net/1842/31357.
Повний текст джерелаFujita, Haruyuki. "The tyrosine kinase inhibitor dasatinib suppresses cytokine production by plasmacytoid dendritic cells by targeting endosomal transport of CpG DNA." Kyoto University, 2013. http://hdl.handle.net/2433/174784.
Повний текст джерелаKatsoulas, Athanasia. "Design and mechanism of action of novel agents termed "combi-molecules" engineered for tandem targeting for Bcr-abl expressing leukemia cells." Thesis, McGill University, 2007. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=111884.
Повний текст джерелаLai, Damian. "Targeting tyrosine kinase inhibitor-insensitive chronic myeloid leukemia stem/progenitor cells by effective inhibition of a novel PP2A-AHI-1-BCR-ABL-JAK2-complex." Thesis, University of British Columbia, 2015. http://hdl.handle.net/2429/54591.
Повний текст джерелаMedicine, Faculty of
Medicine, Department of
Experimental Medicine, Division of
Graduate
Sørum, Christopher. "Synthesis of new tyrosine kinase inhibitors." Thesis, Norges teknisk-naturvitenskapelige universitet, Institutt for kjemi, 2009. http://urn.kb.se/resolve?urn=urn:nbn:no:ntnu:diva-6863.
Повний текст джерелаDoepfner, Kathrin T. "Targeting receptor tyrosine kinase signaling in acute myeloid leukemia /." Zürich, 2008. http://opac.nebis.ch/cgi-bin/showAbstract.pl?sys=000253043.
Повний текст джерелаКниги з теми "Tyrosine Kinase Inhibitors Targeting"
Matthews, David J. Targeting protein kinases for cancer therapy. Hoboken, N.J: John Wiley & Sons, 2009.
Знайти повний текст джерелаE, Gerritsen Mary, ed. Targeting protein kinases for cancer therapy. Hoboken, N.J: John Wiley & Sons, 2010.
Знайти повний текст джерелаFocosi, Daniele, ed. Resistance to Tyrosine Kinase Inhibitors. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-46091-8.
Повний текст джерелаPhosphoinositide 3-kinase in health and disease. Heidelberg: Springer Verlag, 2010.
Знайти повний текст джерелаRommel, Christian. Phosphoinositide 3-kinase in Health and Disease: Volume 2. Berlin, Heidelberg: Springer-Verlag Berlin Heidelberg, 2011.
Знайти повний текст джерелаMüller, Gerhard, and Bert Klebl. Protein kinases as drug targets. Weinheim: Wiley-VCH, 2011.
Знайти повний текст джерелаFleischmann, Roy. Signalling pathway inhibitors. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0081.
Повний текст джерелаFocosi, Daniele. Resistance to Tyrosine Kinase Inhibitors. Springer International Publishing AG, 2018.
Знайти повний текст джерелаFocosi, Daniele. Resistance to Tyrosine Kinase Inhibitors. Springer, 2016.
Знайти повний текст джерелаFocosi, Daniele. Resistance to Tyrosine Kinase Inhibitors. Springer, 2016.
Знайти повний текст джерелаЧастини книг з теми "Tyrosine Kinase Inhibitors Targeting"
Khan, Muzammil Muhammad, Deepika Sarvepalli, Mamoon Ur Rashid, Hammad Zafar, Muhammad Shayan Khan, Effa Zahid, Akash Khetpal, et al. "Gastric Cancer: Role of Phytochemicals and Tyrosine Kinase Inhibitors." In Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers, 189–208. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-48405-7_9.
Повний текст джерелаCarboni, Joan M., Mark Wittman, and Fei Huang. "Targeting Insulin-Like Growth Factor Receptor 1 (IGF-1R) and Insulin Receptor Signaling by Tyrosine Kinase Inhibitors in Cancer." In Insulin-like Growth Factors and Cancer, 215–29. Boston, MA: Springer US, 2011. http://dx.doi.org/10.1007/978-1-4614-0598-6_11.
Повний текст джерелаCakar, Burcu, and Erdem Göker. "Tyrosine Kinase Inhibitors." In Breast Disease, 617–31. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-26012-9_36.
Повний текст джерелаCakar, Burcu, and Erdem Göker. "Tyrosine Kinase Inhibitors." In Breast Disease, 529–39. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-16792-9_35.
Повний текст джерелаDuhé, Roy J. "Tyrosine Kinase Inhibitors." In Encyclopedia of Cancer, 1–3. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_6080-2.
Повний текст джерелаDuhé, Roy J. "Tyrosine Kinase Inhibitors." In Encyclopedia of Cancer, 4705–7. Berlin, Heidelberg: Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-46875-3_6080.
Повний текст джерелаDuhé, Roy J. "Tyrosine Kinase Inhibitors." In Encyclopedia of Cancer, 3822–24. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_6080.
Повний текст джерелаAbad, Cybele Lara R., and Raymund R. Razonable. "Tyrosine-Kinase Inhibitors." In Infectious Complications in Biologic and Targeted Therapies, 273–92. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-11363-5_15.
Повний текст джерелаLatham, Antony M., Jayakanth Kankanala, and Sreenivasan Ponnambalam. "Receptor Tyrosine Kinase Inhibitors." In Encyclopedia of Cancer, 1–7. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_7196-1.
Повний текст джерелаLatham, Antony M., Jayakanth Kankanala, and Sreenivasan Ponnambalam. "Receptor Tyrosine Kinase Inhibitors." In Encyclopedia of Cancer, 3940–46. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-46875-3_7196.
Повний текст джерелаТези доповідей конференцій з теми "Tyrosine Kinase Inhibitors Targeting"
Shelton, Abby, Erin Smithberger, Madison Butler, Alex Flores, Ryan Bash, Steve Angus, Noah Sciaky, et al. "Abstract 331: Dynamic kinome targeting reveals kinases involved in acquired resistance to tyrosine kinase inhibitors in EGFR-driven glioblastomas." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-331.
Повний текст джерелаShelton, Abby, Erin Smithberger, Madison Butler, Alex Flores, Ryan Bash, Steve Angus, Noah Sciaky, et al. "Abstract 331: Dynamic kinome targeting reveals kinases involved in acquired resistance to tyrosine kinase inhibitors in EGFR-driven glioblastomas." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-331.
Повний текст джерелаBushman, Destinee, Jared J. Bearss, Venkataswamy Sorna, Hariprasad Vankayalapati, Sunil Sharma, Fenghuang Zhan, and David Bearss. "Abstract 2161: Targeting Bruton's tyrosine kinase (BTK) in multiple myeloma with novel BTK inhibitors." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-2161.
Повний текст джерелаNakazawa, Youya, Satoshi Kawano, Junji Matsui, Yasuhiro Funahashi, Osamu Tohyama, Hiroki Muto, Takayuki Nakagawa, and Tomohiro Matsushima. "Abstract 2980: Maximizing the efficacy of anti-angiogenesis cancer therapy: A multi-targeting strategy by tyrosine kinase inhibitors." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-2980.
Повний текст джерелаAdelaiye-Ogala, Remi M., Sreenivasulu Chintala, Ashley Orillion, May Elbanna, Ben Elzey, Nur Damayanti, Kiersten M. Miles, et al. "Abstract 4170: Targeting androgen receptor overcomes resistance to tyrosine kinase inhibitors in advanced clear cell renal cell carcinoma." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-4170.
Повний текст джерелаPan, Bin, Xiangmin Wang, Kailin Xu, and Takayuki Ikezoe. "Abstract 5892: miR-217 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitors by targeting pro-oncogenic anterior gradient 2." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-5892.
Повний текст джерелаNjatcha, Christian, Mariya Farooqui, Jennifer R. Grandis, and Jill M. Siegfried. "Abstract 4101: Targeting the EGFR/STAT3 axis in NSCLC with resistance to EGFR tyrosine kinase inhibitors using an oligonucleotide-based decoy." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-4101.
Повний текст джерелаSetiady, Yulius Y., Ling Dong, Anna Skaletskaya, Jan Pinkas, Robert J. Lutz, John M. Lambert, and Thomas Chittenden. "Abstract 4513: IMGN289, an EGFR-targeting antibody-drug conjugate, is effective against tumor cells that are resistant to EGFR tyrosine kinase inhibitors." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-4513.
Повний текст джерелаPaolo, Daniela D., Laura Emionite, George Liu, Michele Cilli, Annarita D. Fiore, Chiara Brignole, Chris Liang, et al. "Abstract 2622: New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs againstALK." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-2622.
Повний текст джерелаRai, Kammei, Nagio Takigawa, Sachio Ito, Katsuyuki Kiura, Tateji Yasuda, Kenji Shimizu, and Mitsune Tanimoto. "Abstract 1158: Multiple molecular targeting effects by miR-7 in EGFR tyrosine kinase inhibitor-resistant lung cancer xenograft models." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-1158.
Повний текст джерелаЗвіти організацій з теми "Tyrosine Kinase Inhibitors Targeting"
Miller, Tod. Peptide-Bassed Inhibitors of Neu Tyrosine Kinase. Fort Belvoir, VA: Defense Technical Information Center, June 1999. http://dx.doi.org/10.21236/ada375133.
Повний текст джерелаMiller, W. T. Peptide-Based Inhibitors of Neu Tyrosine Kinase. Fort Belvoir, VA: Defense Technical Information Center, December 2000. http://dx.doi.org/10.21236/ada392289.
Повний текст джерелаRosen, Neal. Development of Targeted Ansamycins as Novel Antiestrogens and Tyrosine Kinase Inhibitors. Fort Belvoir, VA: Defense Technical Information Center, September 1998. http://dx.doi.org/10.21236/ada369205.
Повний текст джерелаRosen, Neal. Development of Targeted Ansamycins as Noval Antiestrogens and Tyrosine Kinase Inhibitors. Fort Belvoir, VA: Defense Technical Information Center, September 2000. http://dx.doi.org/10.21236/ada413599.
Повний текст джерелаDrake, Justin, and Owen Witte. Identification and Targeting of Tyrosine Kinase Activity in Prostate Cancer Initiation, Progression, and Metastasis. Fort Belvoir, VA: Defense Technical Information Center, October 2012. http://dx.doi.org/10.21236/ada575949.
Повний текст джерелаDrake, Justin, and Owen Witte. Identification and Targeting of Tyrosine Kinase Activity in Prostate Cancer Initiation, Progression, and Metastasis. Fort Belvoir, VA: Defense Technical Information Center, December 2013. http://dx.doi.org/10.21236/ada595692.
Повний текст джерелаBalk, Steven P. Identification and Targeting of Upstream Tyrosine Kinases Mediating PI3 Kinase Activation in PTEN Deficient Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, June 2010. http://dx.doi.org/10.21236/ada535588.
Повний текст джерелаBalk, Steven P. Identification and Targeting of Upstream Tyrosine Kinases Mediating PI3 Kinase Activation in PTEN-Deficient Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, June 2009. http://dx.doi.org/10.21236/ada510490.
Повний текст джерелаBalk, Steven P. Identification and Targeting of Upstream Tyrosine Kinases Mediating PI3 Kinase Activation in PTEN Deficient Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, June 2011. http://dx.doi.org/10.21236/ada550805.
Повний текст джерелаTinker, Anna V., Neesha C. Dhani, Prafull Ghatage, Deanna McLeod, Vanessa Samouëlian, Stephen A. Welch, and Alon D. Altman. Immune Checkpoint Inhibitors in Pretreated Metastatic Endometrial Cancer. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2023. http://dx.doi.org/10.37766/inplasy2023.1.0038.
Повний текст джерела